Edward Kim

Title(s)Associate Professor, MED: Int Med Hematology/Oncology
SchoolSchool of Medicine
AddressCancer Ctr South #3016
CA 95817
Phone916-734-3772
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Student Projects

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Effect and Safety of Radiation Therapy Boost to Extramesorectal Lymph Nodes in Rectal Cancer. Pract Radiat Oncol. 2020 Sep - Oct; 10(5):e372-e377. Chen H, Nguyen KNB, Huang H, Feng C, Zhao X, Daly ME, Rao S, Fragoso R, Valicenti R, Sekhon S, Navarro SM, Kim EJ, Cho M, Tam K, Farkas L, Halabi WJ, Monjazeb AM, Rong Y. PMID: 31866577.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    2. Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resectable Pancreatic Cancer. Int J Radiat Oncol Biol Phys. 2020 01 01; 106(1):124-133. Tran NH, Sahai V, Griffith KA, Nathan H, Kaza R, Cuneo KC, Shi J, Kim E, Sonnenday CJ, Cho CS, Lawrence TS, Zalupski MM. PMID: 31494181; PMCID: PMC7245020.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    3. Efficacy of PD-1 Blockade in Refractory Microsatellite-Stable Colorectal Cancer With High Tumor Mutation Burden. Clin Colorectal Cancer. 2019 12; 18(4):307-309. Gong J, Robertson MD, Kim E, Fakih M, Schrock AB, Tam KW, Burugapalli B, Monjazeb AM, Hendifar AE, Hitchins M, Klempner SJ, Cho M. PMID: 31563511.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    4. PD-1 Blockade in a Liver Transplant Recipient With Microsatellite Unstable Metastatic Colorectal Cancer and Hepatic Impairment. J Natl Compr Canc Netw. 2019 09 01; 17(9):1026-1030. Chen JA, Esteghamat N, Kim EJ, Garcia G, Gong J, Fakih MG, Bold RJ, Cho MT. PMID: 31487676.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    5. Novel Synergistic Combination of Mitotic Arrest and Promotion of Apoptosis for Treatment of Pancreatic Adenocarcinoma. Transl Oncol. 2019 Apr; 12(4):683-692. Duan Z, Chinn D, Tu MJ, Zhang QY, Huynh J, Chen J, Mack P, Yu AM, Kim EJ. PMID: 30844579; PMCID: PMC6402293.
      View in: PubMed   Mentions: 10  
    6. Preclinical Development and First-in-Human Imaging of the Integrin αvβ6 with [18F]αvβ6-Binding Peptide in Metastatic Carcinoma. Clin Cancer Res. 2019 02 15; 25(4):1206-1215. Hausner SH, Bold RJ, Cheuy LY, Chew HK, Daly ME, Davis RA, Foster CC, Kim EJ, Sutcliffe JL. PMID: 30401687; PMCID: PMC6377828.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimals
    7. Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models. Cancer Lett. 2019 02 01; 442:82-90. Tu MJ, Ho PY, Zhang QY, Jian C, Qiu JX, Kim EJ, Bold RJ, Gonzalez FJ, Bi H, Yu AM. PMID: 30389433; PMCID: PMC6311422.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    8. Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Cancer Discov. 2018 09; 8(9):1112-1129. Tiriac H, Belleau P, Engle DD, Plenker D, Deschênes A, Somerville TDD, Froeling FEM, Burkhart RA, Denroche RE, Jang GH, Miyabayashi K, Young CM, Patel H, Ma M, LaComb JF, Palmaira RLD, Javed AA, Huynh JC, Johnson M, Arora K, Robine N, Shah M, Sanghvi R, Goetz AB, Lowder CY, Martello L, Driehuis E, LeComte N, Askan G, Iacobuzio-Donahue CA, Clevers H, Wood LD, Hruban RH, Thompson E, Aguirre AJ, Wolpin BM, Sasson A, Kim J, Wu M, Bucobo JC, Allen P, Sejpal DV, Nealon W, Sullivan JD, Winter JM, Gimotty PA, Grem JL, DiMaio DJ, Buscaglia JM, Grandgenett PM, Brody JR, Hollingsworth MA, O'Kane GM, Notta F, Kim E, Crawford JM, Devoe C, Ocean A, Wolfgang CL, Yu KH, Li E, Vakoc CR, Hubert B, Fischer SE, Wilson JM, Moffitt R, Knox J, Krasnitz A, Gallinger S, Tuveson DA. PMID: 29853643; PMCID: PMC6125219.
      View in: PubMed   Mentions: 458     Fields:    Translation:HumansCells
    9. A Phase II Study of Biweekly Cisplatin, Fixed-Dose-Rate Gemcitabine and Infusional 5-Fluorouracil in Patients With Metastatic Pancreatic and Biliary Cancers. Am J Clin Oncol. 2018 02; 41(2):128-132. Davis EJ, Griffith KA, Kim EJ, Ruch JM, McDonnell KJ, Zalupski MM. PMID: 26535993; PMCID: PMC4854803.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    10. Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis. Cell. 2017 Aug 24; 170(5):875-888.e20. Roe JS, Hwang CI, Somerville TDD, Milazzo JP, Lee EJ, Da Silva B, Maiorino L, Tiriac H, Young CM, Miyabayashi K, Filippini D, Creighton B, Burkhart RA, Buscaglia JM, Kim EJ, Grem JL, Lazenby AJ, Grunkemeyer JA, Hollingsworth MA, Grandgenett PM, Egeblad M, Park Y, Tuveson DA, Vakoc CR. PMID: 28757253; PMCID: PMC5726277.
      View in: PubMed   Mentions: 235     Fields:    Translation:HumansAnimalsCells
    11. Phase II Study of Dovitinib in Patients Progressing on Anti-Vascular Endothelial Growth Factor Therapy. Cancer Treat Res Commun. 2017; 10:21-26. Semrad TJ, Kim EJ, Tanaka MS, Sands J, Roberts C, Burich RA, Li Y, Gandara DR, Lara P, Mack PC. PMID: 28736761; PMCID: PMC5519297.
      View in: PubMed   Mentions: 13     Fields:    
    12. A phase I trial of cabozantinib and gemcitabine in advanced pancreatic cancer. Invest New Drugs. 2016 12; 34(6):733-739. Zhen DB, Griffith KA, Ruch JM, Camphausen K, Savage JE, Kim EJ, Sahai V, Simeone DM, Zalupski MM. PMID: 27439894; PMCID: PMC7458140.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    13. MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesis. Oncotarget. 2016 Jul 19; 7(29):45547-45561. Tu MJ, Pan YZ, Qiu JX, Kim EJ, Yu AM. PMID: 27322206; PMCID: PMC5216741.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    14. The Role of Image-guided Radiotherapy in the Treatment of Anorectal Cancer Using Prone Belly-board Positioning. Anticancer Res. 2016 Jun; 36(6):3013-7. Miyamoto J, Michaud AL, Harandi NK, Kim EJ, Semrad T, Khatri V, Mayadev J, Perks J, Monjazeb AM. PMID: 27272819.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Molecular testing to optimize therapeutic decision making in advanced colorectal cancer. J Gastrointest Oncol. 2016 Apr; 7(Suppl 1):S11-20. Semrad TJ, Kim EJ. PMID: 27034809; PMCID: PMC4783624.
      View in: PubMed   Mentions: 4  
    16. Phase II clinical trials on investigational drugs for the treatment of pancreatic cancers. Expert Opin Investig Drugs. 2015 Jun; 24(6):781-94. Kim EJ, Semrad TJ, Bold RJ. PMID: 25809274; PMCID: PMC4684166.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    17. Pilot clinical trial of hedgehog pathway inhibitor GDC-0449 (vismodegib) in combination with gemcitabine in patients with metastatic pancreatic adenocarcinoma. Clin Cancer Res. 2014 Dec 01; 20(23):5937-5945. Kim EJ, Sahai V, Abel EV, Griffith KA, Greenson JK, Takebe N, Khan GN, Blau JL, Craig R, Balis UG, Zalupski MM, Simeone DM. PMID: 25278454; PMCID: PMC4254161.
      View in: PubMed   Mentions: 147     Fields:    Translation:HumansCellsCTClinical Trials
    18. Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker results. Int J Clin Oncol. 2015 Jun; 20(3):518-24. Semrad T, Barzi A, Lenz HJ, Hutchins IM, Kim EJ, Gong IY, Tanaka M, Beckett L, Holland W, Burich RA, Snyder-Solis L, Mack P, Lara PN. PMID: 25091263; PMCID: PMC4318776.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    19. Quality of life in a prospective, multicenter phase 2 trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys. 2014 Oct 01; 90(2):270-7. Serrano PE, Herman JM, Griffith KA, Zalupski MM, Kim EJ, Bekaii-Saab TS, Ben-Josef E, Dawson LA, Ringash J, Wei AC. PMID: 25104069; PMCID: PMC4751588.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    20. Impact of low testosterone on response to treatment with tadalafil 5 mg once daily for erectile dysfunction. Urology. 2014 Jun; 83(6):1326-33. Goldfischer ER, Kim ED, Seftel AD, Baygani SK, Burns PR. PMID: 24726311.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    21. The Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer. PLoS One. 2014; 9(3):e91983. Abel EV, Kim EJ, Wu J, Hynes M, Bednar F, Proctor E, Wang L, Dziubinski ML, Simeone DM. PMID: 24647545; PMCID: PMC3960140.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansAnimalsCells
    22. Exogenous testosterone: a preventable cause of male infertility. Transl Androl Urol. 2013 Jun; 2(2):106-13. Crosnoe LE, Grober E, Ohl D, Kim ED. PMID: 26813847; PMCID: PMC4708215.
      View in: PubMed   Mentions: 29  
    23. A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer. Cancer. 2013 Aug 01; 119(15):2692-700. Kim EJ, Ben-Josef E, Herman JM, Bekaii-Saab T, Dawson LA, Griffith KA, Francis IR, Greenson JK, Simeone DM, Lawrence TS, Laheru D, Wolfgang CL, Williams T, Bloomston M, Moore MJ, Wei A, Zalupski MM. PMID: 23720019; PMCID: PMC4174603.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCTClinical Trials
    24. Hedgehog signaling pathway and cancer therapeutics: progress to date. Drugs. 2013 May; 73(7):613-23. Ruch JM, Kim EJ. PMID: 23605693.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    25. Molecular Targeted Therapies in Pancreatic Cancer. . 2013 Jan 1; 117-144. Kim KE, Abel AE, Ghosh GA, Simeone SD. .
      View in: Publisher Site   Mentions:
    26. Neoadjuvant chemotherapy with capecitabine and temozolomide for unresectable pancreatic neuroendocrine tumor. Case Rep Oncol. 2012 Sep; 5(3):622-6. Devata S, Kim EJ. PMID: 23275776; PMCID: PMC3531952.
      View in: PubMed   Mentions: 7  
    27. Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-Notch signaling in both tumor and vasculature cells. Clin Cancer Res. 2012 Oct 01; 18(19):5374-86. Yen WC, Fischer MM, Hynes M, Wu J, Kim E, Beviglia L, Yeung VP, Song X, Kapoun AM, Lewicki J, Gurney A, Simeone DM, Hoey T. PMID: 22952347.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
    28. Systemic therapy for advanced gastrointestinal stromal tumors: beyond imatinib. J Surg Oncol. 2011 Dec; 104(8):901-6. Kim EJ, Zalupski MM. PMID: 22069175.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    29. Advances in pancreatic cancer. Curr Opin Gastroenterol. 2011 Sep; 27(5):460-6. Kim EJ, Simeone DM. PMID: 21778878.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    30. The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer. 2005 Jun 06; 92(11):1955-8. Helfman DM, Kim EJ, Lukanidin E, Grigorian M. PMID: 15900299; PMCID: PMC2361793.
      View in: PubMed   Mentions: 90     Fields:    Translation:Humans
    31. Characterization of the metastasis-associated protein, S100A4. Roles of calcium binding and dimerization in cellular localization and interaction with myosin. J Biol Chem. 2003 Aug 08; 278(32):30063-73. Kim EJ, Helfman DM. PMID: 12756252.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    32. Regulation of coiled-coil assembly in tropomyosins. J Struct Biol. 2002 Jan-Feb; 137(1-2):176-83. Araya E, Berthier C, Kim E, Yeung T, Wang X, Helfman DM. PMID: 12064944.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    Edward's Networks
    Concepts (214)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (24)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California